LEMAITRE VASCULAR, INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities
LEMAITRE VASCULAR, INC. (LMAT) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities of $609.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities · last filed 2026-08-05
- 2026-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities $609.00K.
- 2026-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities $471.00K.
- 2025-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities $624.00K.
- 2024-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities $0.00.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities |
|---|---|
| 2026-06-30 | $609.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $471.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $624.00K 10-Q · filed 2026-08-05 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.38M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.35M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.41M 10-K · filed 2025-02-28 |
| 2023-09-30 | $1.38M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.49M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.46M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.35M 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.61M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.66M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $1.71M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.76M 10-K · filed 2023-03-01 |
| 2021-09-30 | $2.71M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $3.66M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $3.68M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.70M 10-K · filed 2022-02-28 |
| 2020-09-30 | $3.78M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $4.20M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $3.31M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $3.27M 10-K · filed 2021-03-12 |
| 2019-09-30 | $2.09M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $1.35M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $1.34M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $1.33M 10-K · filed 2020-03-12 |
| 2018-09-30 | $1.11M 10-Q · filed 2018-11-02 |
| 2018-03-31 | $36.00K 10-Q · filed 2018-05-04 |
| 2017-12-31 | $127.00K 10-K · filed 2019-03-11 |
| 2017-09-30 | $159.00K 10-Q · filed 2017-11-03 |
| 2017-06-30 | $1.56M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $1.40M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $1.25M 10-K · filed 2018-03-09 |
| 2015-12-31 | $265.00K 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |